secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0001193125-24-271540
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines raises ~$823M in underwritten public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Offering of 16,576,088 common shares and pre-funded warrants for 2,173,917 shares closed Dec 5, 2024.
- Public price $46.00 per share / $45.9999 per pre-funded warrant; underwriters purchased at $43.93/$43.9299.
- Net proceeds ~$823M after discounts and expenses; underwriters' option exercised in full.
- 45-day lock-up on share sales by directors, officers and the company, subject to exceptions.
- Underwriting led by J.P. Morgan, TD Securities, Goldman Sachs & Guggenheim Securities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312524271540/0001193125-24-271540-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312524271540/d865739d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-271540

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer